Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donnell Bowen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Molecular Graphics & Modelling|October 11, 2005
Barnase thermal titration via molecular dynamics simulations: detection of early denaturation sitesJian Yin, Donnell Bowen, William M Southerland
Anticancer Research|January 5, 2007
The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexateJharna R Das, Elizabeth B Fryar, S Green, et al.
Anticancer Research|July 11, 2006
Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexateJharna R Das, Elizabeth B Fryar, Nicolas N Epie, et al.
Anticancer Research|May 17, 2002
Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cellsJoseph A De Soto, Donnell Bowen, Jillian H Davis, et al.
Anticancer Research|May 1, 2007
Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrowJharna R Das, Elizabeth B Fryar-Tita, Sidney Green, et al.
Anticancer Research|January 30, 2008
Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrowJharna R Das, Elizabeth B Fryar-Tita, Yanfei Zhou, et al.
Plos Computational Biology|June 19, 2007
Ligand binding and circular permutation modify residue interaction network in DHFRZengjian Hu, Donnell Bowen, William M Southerland, et al.
Anticancer Research|July 11, 2006
Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapyElizabeth B Fryar, Jharna R Das, Jillian H Davis, et al.
Anticancer Research|June 29, 2007
Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapiesElizabeth B Fryar-Tita, Jharna R Das, J H Davis, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Molecular Graphics & Modelling|October 11, 2005
Barnase thermal titration via molecular dynamics simulations: detection of early denaturation sitesJian Yin, Donnell Bowen, William M Southerland
Anticancer Research|January 5, 2007
The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexateJharna R Das, Elizabeth B Fryar, S Green, et al.
Anticancer Research|July 11, 2006
Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexateJharna R Das, Elizabeth B Fryar, Nicolas N Epie, et al.
Anticancer Research|May 17, 2002
Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cellsJoseph A De Soto, Donnell Bowen, Jillian H Davis, et al.
Anticancer Research|May 1, 2007
Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrowJharna R Das, Elizabeth B Fryar-Tita, Sidney Green, et al.
Anticancer Research|January 30, 2008
Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrowJharna R Das, Elizabeth B Fryar-Tita, Yanfei Zhou, et al.
Plos Computational Biology|June 19, 2007
Ligand binding and circular permutation modify residue interaction network in DHFRZengjian Hu, Donnell Bowen, William M Southerland, et al.
Anticancer Research|July 11, 2006
Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapyElizabeth B Fryar, Jharna R Das, Jillian H Davis, et al.
Anticancer Research|June 29, 2007
Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapiesElizabeth B Fryar-Tita, Jharna R Das, J H Davis, et al.
Pageof 1